Dr. Jugalkishor Tujlashanker Raval MD

Recommended Articles

• OSU Doctor Is A Leader in the Fight Against Alzheimer's Disease

  Alzheimer’s gradually takes away a patient's memories, personality, ambition, and their daily routine.  It is an insidious disease, and very few are exempt from the signs of Alzheimer’s and dementia. In fact, over 70 percent of the elderly currently have some form of dementia. ...

• Understanding Parkinson’s Disease Through Falling

  Parkinson’s disease is commonly known to be a progressive disorder in the nervous system which affects an individual’s movement. A well-known sign of Parkinson’s disease is a tremor usually noticeable in just one hand. Stiffness or slow movement is also caused by the disease. In the US, there...

• Multiple Sclerosis Treatments Are Becoming More Effective, but Are Underfunded

  Multiple sclerosis is considered a relatively rare disease, but a recent MS guideline published by the National Institute for Health and Care Excellence stated that with more than 400,000 cases in the US alone, MS has become the leading cause of physical disability in working age adults.Although...

• Companies Want to Work with People Who Have Autism

  In the United States, statistics indicate that as many as 80-90% of adults on the autism spectrum are either unemployed or underemployed. These poor outcomes are not the result of an inability among individuals with autism to demonstrate their competence and to perform job tasks. Rather, for the...

• How Do People Get Lyme Disease?

  Lyme disease is found all over the world, with the only exception being Antarctica, which means that it is possible to get the disease virtually anywhere in the world.What Causes Lyme disease?The main cause of Lyme disease is a spirochetal bacteria found under the Borrelia genus collectively known...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...